Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Docetaxel in First-Line Advanced NSCLC
NCT00840125Phase 2Completed
- Sponsor
- Meir Medical Center
- Start
- Feb 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Meir Medical Center. Started Feb 2009; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00840125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840125.